BioTissue - About the company
BioTissue is a series C company based in Miami (United States), founded in 2001. It operates as a Developer of regenerative biologic therapies for eye care. BioTissue has raised $110M in funding from investors like Ballast Point Ventures, RC Capital and EW Healthcare Partners. The company has 2811 active competitors, including 929 funded and 695 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Tango Therapeutics and Elicio.
Company Details
Developer of regenerative biologic therapies for eye care. The company offers a range of products that aim to help improve patient outcomes in regenerative wound healing AmnioGraft, Prokera, Neox 1K, and more.
- Website
- biotissue.com
- Phone Number
- +1 **********
- Registered Address
- Miami, Florida
Key Metrics
Founded Year
2001
Location
Miami, United States
Stage
Series C
Total Funding
$110M in 19 rounds
Latest Funding Round
Investors
Ranked
498th among 2811 active competitors
Employee Count
376 as on Sep 30, 2026
Similar Companies
Legal entities associated with BioTissue
BioTissue is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Tissuetech, Inc. CIN: 20131722241 , United States, Deadpooled | Dec 19, 2013 | $5M - $25M (As on Oct 10, 2013) | - | - |
TISSUE TECH, INC CIN: 651116071 , United States, Active | Dec 31, 1999 | - | 311 (As on Dec 31, 2024) | - |
Sign up to download BioTissue's company profile
BioTissue's funding and investors
BioTissue has raised a total funding of $110M over 19 rounds. Its first funding round was on Sep 15, 2006. Its latest funding round was a Grant (prize money) round on Jun 21, 2021 for $*****. 1 investor participated in its latest round. BioTissue has 4 institutional investors.
Here is the list of recent funding rounds of BioTissue:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 21, 2021 | 6896607 | Grant (prize money) | 5005627 | 7376623 | 1978747 | 4635146 |
Apr 12, 2019 | 3428600 | Series C | 1453584 | 5939821 | 6755892 | |
Nov 18, 2016 | 4076986 | Grant (prize money) | 4873741 | 9492227 | 9898402 |
View details of BioTissue's funding rounds and investors
BioTissue's founders and board of directors
Founder? Claim ProfileBioTissue's employee count trend
BioTissue has 376 employees as of Sep 26. Here is BioTissue's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BioTissue's Competitors and alternates
Top competitors of BioTissue include Jazz Pharmaceuticals, Tango Therapeutics and Elicio. Here is the list of Top 10 competitors of BioTissue, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd | Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | 72/100 | |
3rd | Elicio 2012, Cambridge (United States), Public | Developer of vaccines for treating cancer | $47.4M | 72/100 | |
4th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
5th | Developer of immunotherapeutics for the treatment of cancer and other diseases | $861M | 71/100 | ||
6th | Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 71/100 | |
7th | Viridian Therapeutics 2007, Boulder (United States), Public | Developer of medicines for patients with serious and rare diseases | $14.5M | 71/100 | |
8th | Developer of antibody based drugs for angiogenesis-related cancer and inflammatory disorders | $69.7M | 70/100 | ||
9th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 70/100 | |
10th | Deciphera 2003, Waltham (United States), Acquired | Developer of type 2 kinase inhibitors for treating cancer | $173M | 70/100 | |
498th | BioTissue 2001, Miami (United States), Series C | Developer of regenerative biologic therapies for eye care | $110M | 49/100 |
Looking for more details on BioTissue's competitors? Click here to see the top ones
BioTissue's Investments and acquisitions
BioTissue has made no investments or acquisitions yet.
Reports related to BioTissue
Here is the latest report on BioTissue's sector:
News related to BioTissue
Media has covered BioTissue for a total of 2 events in the last 1 year.
•
BioStem Technologies Acquires BioTissue Holdings’ Surgical and Wound Care BusinessMedical Product Outsourcing•Jan 22, 2026•BioStem Technologies, BioTissue
•
•
BioTissue Introduces CAM360 AmnioGraft Regenerative Therapy for Dry Eye and Ocular Surface DisordersEyewire News•Jun 03, 2024•BioTissue
•
•
TissueTech Announces Rebranding, Adopts BioTissue Name Across Entire BusinessBusiness Wire•Feb 09, 2022•BioTissue, TissueTech, Amniox Medical
•
Ted Davis to Succeed Amy Tseng as President and CEO of TissueTechBusiness Wire•Jan 27, 2022•BioTissue
•
Dendreon Pharmaceuticals Appoints Sherry Saurini as Vice President of QualityBusiness Wire•Aug 23, 2021•Dendreon, BioTissue
•
Bio-Tissue Receives FDA Clearance to Proceed with Clinical Study Using Investigational New Drug TTBT01Eyewire News•Mar 01, 2021•BioTissue
•
BioSig Technologies appoints Brenda Castrodad to lead its Human Resources departmentProactive Investors•Feb 16, 2021•BioSig, BioTissue
•
Are you a Founder ?
FAQs about BioTissue
Explore our recently published companies
- Haase Nauen - Garbsen based, Unfunded company
- Niemerszein - Hamburg based, Unfunded company
- Infinity Share - Germany based, 2020 founded, Unfunded company
- Spedition Pape - Germany based, Unfunded company
- Estream International - Germany based, 2019 founded, Public company
- Genussakademie Bayern - Kulmbach based, 2017 founded, Unfunded company
